This issue of the Heart Failure Clinics of North America, guest edited by Drs. Daniel Lenihan and Douglas Sawyer, will cover several aspects of Cardio-oncology Related to Heart Failure. Subjects discussed in the volume include, but are not limited to: Proteasome Inhibitors as a potential cause of Heart Failure; EGFR target based therapy; Amyloidosis; How to manage Heart Failure in a patient with cancer; Advanced HF/Txp; Epidemiology and common risk factors; Pediatric Considerations; Alternative biomarkers for combined biology; How to develop a Cardio-Oncology Clinic; and How to structure a Cardio-Oncology fellowship program, among others.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Management of Heart Failure in Cancer Patients and Cancer Survivors - p. 253 9. Proteasome Inhibitors as a Potential Cause of Heart Failure - p. 289 10. Cardio-oncology Related to Heart Failure: Epidermal Growth Factor Receptor Target-Based Therapy - p. 297 11. Cardio-oncology Related to Heart Failure: Pediatric Considerations for Cardiac Dysfunction - p. 311 12. Advanced Heart Failure Therapies for Cancer Therapeutics–Related Cardiac Dysfunction - p. 327 13. Cardiac Dysfunction and Heart Failure in Hematopoietic Cell Transplantation Survivors: Emerging Paradigms in Pathophysiology, Screening, and Prevention - p. 337 14. How to Develop a Cardio-Oncology Clinic - p. 347 15. How to Develop a Cardio-oncology Fellowship - p. 361 16. Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease - p. 367 17. Alternative Biomarkers for Combined Biology - p. 381 18. Cardio-oncology: The Role of Big Data - p. 403 19. Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration - p. 409
This issue of the Heart Failure Clinics of North America, guest edited by Drs. Daniel Lenihan and Douglas Sawyer, will cover several aspects of Cardio-oncology Related to Heart Failure. Subjects discussed in the volume include, but are not limited to: Proteasome Inhibitors as a potential cause of Heart Failure; EGFR target based therapy; Amyloidosis; How to manage Heart Failure in a patient with cancer; Advanced HF/Txp; Epidemiology and common risk factors; Pediatric Considerations; Alternative biomarkers for combined biology; How to develop a Cardio-Oncology Clinic; and How to structure a Cardio-Oncology fellowship program, among others.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Management of Heart Failure in Cancer Patients and Cancer Survivors - p. 253 9. Proteasome Inhibitors as a Potential Cause of Heart Failure - p. 289 10. Cardio-oncology Related to Heart Failure: Epidermal Growth Factor Receptor Target-Based Therapy - p. 297 11. Cardio-oncology Related to Heart Failure: Pediatric Considerations for Cardiac Dysfunction - p. 311 12. Advanced Heart Failure Therapies for Cancer Therapeutics–Related Cardiac Dysfunction - p. 327 13. Cardiac Dysfunction and Heart Failure in Hematopoietic Cell Transplantation Survivors: Emerging Paradigms in Pathophysiology, Screening, and Prevention - p. 337 14. How to Develop a Cardio-Oncology Clinic - p. 347 15. How to Develop a Cardio-oncology Fellowship - p. 361 16. Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease - p. 367 17. Alternative Biomarkers for Combined Biology - p. 381 18. Cardio-oncology: The Role of Big Data - p. 403 19. Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration - p. 409
